Cantor Fitzgerald analyst Eric Schmidt reiterated an Overweight ratingon Bicara Therapeutics Inc (NASDAQ: BCAX).The analyst commented, "Multiple good options coming ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE